Q-omics provides the consensus-scored MIR4304 profile across patient tissues and cancer cell-line models. MIR4304 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, MIR4304 is differentially expressed in 1, with the highest sampling consensus in KICH. Additionally, MIR4304 RNA expression shows 8,516 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight BLCA, KICH, and BRCA as cancer lineages where MIR4304 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR4304 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR4304 survival associations across molecular data types. MIR4304 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR4304 RNA expression–survival associations across cancer types. High MIR4304 expression shows unfavorable associations in BLCA, LUSC, OV, UCEC and THCA, but favorable associations in LAML. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for MIR4304 RNA expression.
This table summarizes MIR4304 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for MIR4304. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR4304 shows lower tumor expression in KICH. The KICH box plot shows higher MIR4304 RNA expression in normal versus tumor tissue (log2 FC = −0.243, t-test p = .032).
This table shows molecular features associated with MIR4304 in patient tissues and cancer cell lines. In patient samples, MIR4304 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set.
